Press Releases

05.28.2015

Pfizer Global Survey Finds Adults with Rheumatoid Arthritis Who Feel Comfortable Speaking Up About Their Concerns Have a More Positive View of Their Health

05.19.2015

Pfizer Invites Public to View and Listen to Webcast of June 2 Conference Call with Analysts to Review Oncology Business and ASCO Data Presentations

05.14.2015

Pfizer Receives Request For Additional Information From FTC Regarding Proposed Acquisition Of Hospira

05.14.2015

Bar Ilan University to work with Pfizer Inc. to evaluate drug delivery via DNA Nanorobots

05.14.2015

Marc Tessier-Lavigne, Ph.D. to Leave Pfizer Board of Directors

05.13.2015

Merck KGaA, Darmstadt, Germany, and Pfizer to Present Data at ASCO for Avelumab, an Investigational Anti-PD-L1 Antibody

05.11.2015

Pfizer Acquires Minority Interest in AM-Pharma; Secures Option to Acquire Company

05.06.2015

Pfizer Appoints New Leaders for BioTherapeutics Research & Development and Rinat

05.05.2015

23andMe Launches Lupus Research Community in Collaboration with Pfizer Inc.

04.28.2015

PFIZER REPORTS FIRST-QUARTER 2015 RESULTS

04.23.2015

Pfizer Hosts Annual Meeting Of Shareholders

04.21.2015

Pfizer Receives U.S. FDA Breakthrough Therapy Designation For XALKORI® (crizotinib) For The Treatment Of Patients With ROS1-Positive Non-Small Cell Lung Cancer